Alpine Global Management’s Edwards Lifesciences EW Stock Holding History

Alpine Global Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,891	Closed	-$245K	–	354
2020 Q1	$245K	Sell	3,891 -588	-13%	-$42.4K	0.05%	152
2019 Q4	$348K	Buy	+4,479	New	+$350K	0.07%	233
2015 Q3	–	Sell	-1,878	Closed	-$45K	–	333
2015 Q2	$45K	Buy	+1,878	New	+$42.4K	0.01%	801
2015 Q1	–	Sell	-14,016	Closed	-$298K	–	375
2014 Q4	$298K	Buy	+14,016	New	+$282K	0.05%	368

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Alpine Global Management's EW Position: Q2 2020 in Review

Alpine Global Management sold out of Edwards Lifesciences (EW) in Q2 2020, closing a stake of 3,891 shares — an estimated $245K sold.

Alpine Global Management first reported a position in EW in Q4 2014 and held it in 4 quarters. The position peaked at $348K in Q4 2019. 1,048 funds tracked by Wall St. Rank hold EW as of Q2 2020.

Alpine Global Management reported no remaining Edwards Lifesciences position as of Q2 2020 after selling out during the quarter.
Alpine Global Management sold 3,891 Edwards Lifesciences shares in Q2 2020, an estimated $245K.
Alpine Global Management first reported a position in Edwards Lifesciences in Q4 2014 and held it in 4 quarters.
Alpine Global Management's Edwards Lifesciences position peaked at $348K in Q4 2019.
1,048 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2020.

Based on Alpine Global Management's 13F filing for Q2 2020, filed 14 Aug 2020.